324 related articles for article (PubMed ID: 16634625)
1. Antimitotic sulfonamides inhibit microtubule assembly dynamics and cancer cell proliferation.
Mohan R; Banerjee M; Ray A; Manna T; Wilson L; Owa T; Bhattacharyya B; Panda D
Biochemistry; 2006 May; 45(17):5440-9. PubMed ID: 16634625
[TBL] [Abstract][Full Text] [Related]
2. Rotenone inhibits mammalian cell proliferation by inhibiting microtubule assembly through tubulin binding.
Srivastava P; Panda D
FEBS J; 2007 Sep; 274(18):4788-801. PubMed ID: 17697112
[TBL] [Abstract][Full Text] [Related]
3. Kinetic stabilization of microtubule dynamics by estramustine is associated with tubulin acetylation, spindle abnormalities, and mitotic arrest.
Mohan R; Panda D
Cancer Res; 2008 Aug; 68(15):6181-9. PubMed ID: 18676841
[TBL] [Abstract][Full Text] [Related]
4. Antimitotic antifungal compound benomyl inhibits brain microtubule polymerization and dynamics and cancer cell proliferation at mitosis, by binding to a novel site in tubulin.
Gupta K; Bishop J; Peck A; Brown J; Wilson L; Panda D
Biochemistry; 2004 Jun; 43(21):6645-55. PubMed ID: 15157098
[TBL] [Abstract][Full Text] [Related]
5. Taccalonolides E and A: Plant-derived steroids with microtubule-stabilizing activity.
Tinley TL; Randall-Hlubek DA; Leal RM; Jackson EM; Cessac JW; Quada JC; Hemscheidt TK; Mooberry SL
Cancer Res; 2003 Jun; 63(12):3211-20. PubMed ID: 12810650
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of alpha-hydroxymethylated conjugated nitroalkenes for their anticancer activity: inhibition of cell proliferation by targeting microtubules.
Mohan R; Rastogi N; Namboothiri IN; Mobin SM; Panda D
Bioorg Med Chem; 2006 Dec; 14(23):8073-85. PubMed ID: 16891118
[TBL] [Abstract][Full Text] [Related]
7. 3-(Iodoacetamido)-benzoylurea: a novel cancericidal tubulin ligand that inhibits microtubule polymerization, phosphorylates bcl-2, and induces apoptosis in tumor cells.
Jiang JD; Davis AS; Middleton K; Ling YH; Perez-Soler R; Holland JF; Bekesi JG
Cancer Res; 1998 Dec; 58(23):5389-95. PubMed ID: 9850070
[TBL] [Abstract][Full Text] [Related]
8. Discovery of novel 2-N-aryl-substituted benzenesulfonamidoacetamides: orally bioavailable tubulin polymerization inhibitors with marked antitumor activities.
Liu Z; Zhou Z; Tian W; Fan X; Xue D; Yu L; Yu Q; Long YQ
ChemMedChem; 2012 Apr; 7(4):680-93. PubMed ID: 22311585
[TBL] [Abstract][Full Text] [Related]
9. A-204197, a new tubulin-binding agent with antimitotic activity in tumor cell lines resistant to known microtubule inhibitors.
Tahir SK; Han EK; Credo B; Jae HS; Pietenpol JA; Scatena CD; Wu-Wong JR; Frost D; Sham H; Rosenberg SH; Ng SC
Cancer Res; 2001 Jul; 61(14):5480-5. PubMed ID: 11454695
[TBL] [Abstract][Full Text] [Related]
10. Mechanism of inhibition of cell proliferation by Vinca alkaloids.
Jordan MA; Thrower D; Wilson L
Cancer Res; 1991 Apr; 51(8):2212-22. PubMed ID: 2009540
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of microtubule assembly in tumor cells by 3-bromoacetylamino benzoylurea, a new cancericidal compound.
Jiang JD; Wang Y; Roboz J; Strauchen J; Holland JF; Bekesi JG
Cancer Res; 1998 May; 58(10):2126-33. PubMed ID: 9605756
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of action of the microtubule-targeted antimitotic depsipeptide tasidotin (formerly ILX651) and its major metabolite tasidotin C-carboxylate.
Ray A; Okouneva T; Manna T; Miller HP; Schmid S; Arthaud L; Luduena R; Jordan MA; Wilson L
Cancer Res; 2007 Apr; 67(8):3767-76. PubMed ID: 17440090
[TBL] [Abstract][Full Text] [Related]
13. Embelin derivatives and their anticancer activity through microtubule disassembly.
Xu M; Cui J; Fu H; Proksch P; Lin W; Li M
Planta Med; 2005 Oct; 71(10):944-8. PubMed ID: 16254827
[TBL] [Abstract][Full Text] [Related]
14. Dynamics of the mitotic spindle--potential therapeutic targets.
Miyamoto DT; Perlman ZE; Mitchison TJ; Shirasu-Hiza M
Prog Cell Cycle Res; 2003; 5():349-60. PubMed ID: 14593729
[TBL] [Abstract][Full Text] [Related]
15. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
16. Apoptosis induction via microtubule disassembly by an antitumour compound, pironetin.
Kondoh M; Usui T; Nishikiori T; Mayumi T; Osada H
Biochem J; 1999 Jun; 340 ( Pt 2)(Pt 2):411-6. PubMed ID: 10333483
[TBL] [Abstract][Full Text] [Related]
17. A novel oral indoline-sulfonamide agent, N-[1-(4-methoxybenzenesulfonyl)-2,3-dihydro-1H-indol-7-yl]-isonicotinamide (J30), exhibits potent activity against human cancer cells in vitro and in vivo through the disruption of microtubule.
Liou JP; Hsu KS; Kuo CC; Chang CY; Chang JY
J Pharmacol Exp Ther; 2007 Oct; 323(1):398-405. PubMed ID: 17660383
[TBL] [Abstract][Full Text] [Related]
18. beta-Sitosterol induces G2/M arrest, endoreduplication, and apoptosis through the Bcl-2 and PI3K/Akt signaling pathways.
Moon DO; Kim MO; Choi YH; Kim GY
Cancer Lett; 2008 Jun; 264(2):181-91. PubMed ID: 18314257
[TBL] [Abstract][Full Text] [Related]
19. Mechanism of action of E7010, an orally active sulfonamide antitumor agent: inhibition of mitosis by binding to the colchicine site of tubulin.
Yoshimatsu K; Yamaguchi A; Yoshino H; Koyanagi N; Kitoh K
Cancer Res; 1997 Aug; 57(15):3208-13. PubMed ID: 9242451
[TBL] [Abstract][Full Text] [Related]
20. Tanshinone IIA, an isolated compound from Salvia miltiorrhiza Bunge, induces apoptosis in HeLa cells through mitotic arrest.
Zhou L; Chan WK; Xu N; Xiao K; Luo H; Luo KQ; Chang DC
Life Sci; 2008 Sep; 83(11-12):394-403. PubMed ID: 18721815
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]